Scholars Central

Review articlePublished 29 Dec 2022

Multiple Myeloma and Diabetes

Authors: Mira Zantout

Journal of Diabetes & Metabolism

Volume 13 · Issue 12 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Multiple myeloma may be a malignant lymph cell disorder that accounts for about 100% of all medicine cancers. It’s characterised by accumulation of organism plasma cells, preponderantly within the bone marrow. The prevalence of sort two polygenic disorders is increasing; thus, it's expected that there'll be a rise within the diagnosing of myeloma with concomitant diabetes. The treatment of myeloma and diabetes is varied. The bitingness of the 2 conditions during a patient forms a significant challenge for physicians. Keywords: Diagnosis; Disparities; Early diagnosis; Multiple myeloma; Race; Myeloma; Treatment

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Diabetes & Metabolism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes & Metabolism
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Mira Zantout”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels